COMMON STOCK (Details Narrative) - $ / shares |
3 Months Ended | 12 Months Ended | |
---|---|---|---|
Mar. 31, 2024 |
Dec. 31, 2023 |
Jun. 06, 2023 |
|
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Common stock, shares authorized | 25,000,000 | 25,000,000 | 14,285,715 |
Common stock par value | $ 0.007 | $ 0.007 | |
Restricted Stock Units Unvested [Member] | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Unvested number of shares | 297,862 | ||
Common Stock [Member] | |||
Accumulated Other Comprehensive Income (Loss) [Line Items] | |||
Shares of common stock | 11,514,354 | 9,505,255 | |
Unvested number of shares | 110,664 |
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of non-vested options outstanding. No definition available.
|
X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|